Trial Profile
Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Dec 2014
Price :
$35
*
At a glance
- Drugs Difluprednate (Primary)
- Indications Postoperative inflammation
- Focus Therapeutic Use
- Sponsors Sirion Therapeutics
- 23 Dec 2014 New trial record